Summary
Introduction
Ides-Asp'langiotension 11, which is also called angiotensin 111, has recently received much interest. It is produced by the action of aminopeptidases on angiotensin 11. Angiotensin 111 has been reported to be as active as angiotensin 11 in releasing aldosterone from the zona glomerulosa of the adrenal gland in vitro (Blair-West, Coghlan, Denton, Funder, Scoggins & Wright, 1971; Peach & Chiu, 1974) and in vivo (Campbell, Brooks & Pettinger, 1974; Freeman, Davis, Lohmeier & Spielman, 1976) .
The evaluation of the physiological importance of angiotensin I11 has been hampered by the fact that a simple and rapid assay for its determination in plasma and other body fluids is not available. The procedures described in the past have been complicated and time-consuming (Cain, Catt & Coghlan, 1969; Favre, Valloton & Muller, 1974 ; Pullman, Oparil & Carone, 1975 ; Mendelsohn, 1976 ; Semple & Morton, 1976) . This paper reports a relatively simple method for the selective extraction and concentration of angiotensin 111, which combined with a radioimmunoassay allows the rapid measurement of the peptide.
The method was used to study the effect of the /Isympathomimetic amine isoprenaline on plasma concentrations of angiotensin I11 in rats. B u e r D. This was NaCl (0.128 mol/l), sodium barbital (0.018 mol/l) and sodium acetate (0.005 molh), pH 7.4.
Materiels and methods

1251-labelled
T.1.c. medium. Medium for thin-layer chromatography was butan-1 -ol/acetic acid/water (4 : 1 : 1, by vol.).
Standard solutions of angiotensins. 1 mg of a peptide was dissolved in 1 ml of buffer C. The respective working solutions were prepared by further dilution with buffer C. They were quickly frozen in liquid nitrogen and stored at -1 8 O C .
Column separation
Columns. Glass columns with an inner diameter of 0.5 cm were used. The resins were placed on a wad of quartz wool.
Preparation of ion-exchange resins. A batch of 15 g of Bio Rex 70 was prepared for extraction of angiotensin 111. It was washed with 60 ml of NaOH (5 mol/l), 60 ml of HCI (5 mol/l) and twice with 60 ml of water. The pH was adjusted to 6.4 with NaOH (5 molh). For one column 0.7 g of resin was used. Dowex 1 (X8) was also washed before use: 15 g was washed with 60 ml of HCl (5 mol/l), 60 ml of NaOH ( 5 mol/l) and twice with 60 ml of water. The pH was adjusted to 8.9 with HCl (5 mol/l). For one column 0-7 g of resin was used.
Sample taking
Rats were lightly anaesthetized with ether.
Within 20 s 5 ml of aortic blood was collected in a pre-cooled syringe containing 0-8 ml of 'inhibitor solution'. The blood was centrifuged at 2OC for 15 min at 2000 g. The plasma (approx. 3 ml) was extracted immediately.
Extraction of angiotensin
With Bio Rex 70. Portions (1 ml) of the plasma samples were extracted. The pH was adjusted to 6.4 with HCl (1 mol/l). Precipitated proteins necessitated centrifugation (18 000 g, 10 min). The supernatant was mixed with 2 ml of buffer B. This mixture was put on the resin. When the resin had been washed three times with 2 ml of water (pH 6.4), it was eluted with 4 ml of NH, solution (2.0 mol/l). The eluates were concentrated by drying under vacuum.
With Dowex 1 (X8). Portions (1 ml) of the plasma samples were extracted. The pH was adjusted to 8.9 with NaOH (1 mol/l). After centrifugation (1 8 000 g, 10 min) the supernatant was put on the resin. The resin was washed three times with 2 ml of water (pH 8.9) and eluted with 4 ml of acetic acid (1 mol/l). The eluates were concentrated by drying under vacuum. rnl of charcoal suspension (1% in buffer D) was added and centrifuged for 10 min at 2300 g. Radioactivity of the supernatant was counted in a yspectrometer (Packard). The peptides in the eluates of the resins were determined according to the following protocol: the residues were dissolved in 1.2 ml of buffer A. A portion (0.9 ml) and 50 pl of antiserum were mixed and preincubated for 2&24 h. Thereafter, the procedure described for the standard curves was used.
Radioimmunoassay of angiotensins
Thin-layer chromatography
In some experiments eluates from Dowex 1 (X8) and Bio Rex 70 columns were chromatographed on silica-gel plates (butan-1-ol/acetic acid/water, 4 : 1 : 1, by vol.) (Favre et al., 1974) . In this case eluates were dried under vacuum and dissolved in 300 pl of water. A portion (50 A) was added to 50 pl of methanol (pH 3.0) and chromatographed. The plates were developed during 6 h. The plates were scanned for radioactivity with a TLC scanner (Berthold LB 2723). 12sI peaks were scraped off and the radioactivity was counted in a y-spectrometer (Packard).
Recovery of angiotensins
lZsI-labelled angiotensin I1 (approx. 4 pg) or [3H]angiotensin I11 (approx. 15 ng) was added to plasma samples. The samples were then run through the extraction procedure. Recovery (%) was expressed as (radioactivity counts in column eluate before evaporation/counts added) x 100. In some experiments 12sI-labelled angiotensin II (approx. 80 pg) was added to the 0.8 ml of 'inhibitor solution' in the syringe used to collect the blood samples. The plasma obtained was then put on the resins. Recovery (%) was expressed as (radioactivity counts in column eluate before evaporation/counts put on resin) x 100. Some of these eluates were evaporated. The residues were then dissolved and aliquots were used for thin-layer chromatography.
Recoveries of unlabelled angiotensins were performed by adding various amounts of the peptides to plasma samples (before pH adjustment). The amounts of peptides found in the column eluates after evaporation were determined by radioimmunoassay .
Plasma blanks were obtained by using nephrectomized rats. Three hours before blood collection these rats had been bilaterally nephrectomized under light ether anaesthesia. Other blanks were prepared from samples (1 ml) of plasma from normal rats by additon of 0.1 ml of charcoal suspension (10% in buffer D). After centrifugation (2300 g, 15 min) the plasma samples were extracted as described above.
A nima 1 experiments
Male Wistar rats (25G280 g) were used. When the effect of isoprenaline on the plasma concentrations of angiotensins was studied, the amine was given as base weight in a volume of 1 ml/kg body weight. Dose and time schedules used are shown in the Results section.
In some experiments the metabolism of labelled angiotensin I1 was investigated. Eighteen minutes after the intramuscular injection of isoprenaline (500 pglkg) the rats received an infusion into a tail vein. The solution contained approximately 1300 pg of 12s~-labelled angiotensin Wml. Infusion rate was 1 ml/min. The duration of the infusion was 30 s. While the peptide was still being infused the rats were rapidly anaesthetized with ether and bled from the aorta. The plasma samples were extracted and subjected to thin-layer chromatography as described above.
Results
Radioimmunoassay
Equimolar concentrations of angiotensin 11, angiotensin I11 and [des-Asp1,des-Arg21angio-tensin I1 produced a nearly identical inhibition of the binding of 1251-labelled angiotensin I1 (Fig. 1) . The range from 2 to 160 fmol/ml was used for the calculation of the unknown samples. Crossreactivity of the system with angiotensin I was 0.5%.
Recovery studies
Increasing amounts of angiotensin I1 (24-380 fmol) were added to samples (1 ml) of plasma before their extraction with Dowex 1 (X8) (Fig. 2) .
On average, 54% could be recovered with the radioimmunoassay in the eluates. The intra-assay variability (sD/mean) was 14%; the interassay variability (sD/mean of means of several determinations) was 12%. The recovery of [des-Asp',desArg2]angiotensin I1 after extraction with Dowex 1 (X8) was similar. From 260 or 520 fmol added to the plasma, 51% (SD 6; n = 8) was recovered.
However, Dowex 1 (X8) did not extract andotensin 111. Even after the addition of 660 fmol to plasma samples no angiotensin I11 could be found in the Dowex 1 (X8) eluates. Bilateral nephrectomy, 3 h before blood collection, decreased the plasma concentration of angiotensins to barely detectable values (<5 fmol/ml). After pretreatment of control plasma with charcoal no andotensin-like activity was found. Fig. 2 also shows the recovery of angiotensin I11 after the extraction of the plasma samples with Bio Rex 70. When 17-5-220 fmol was added to samples (1 ml) of plasma, mean recovery was 62%. The intra-assay variability was 10%; interassay The efficiency of the 'inhibitor solution', which was used to inactivate angiotensin-metabolizing enzymes during collection of blood or in the following procedure, was also tested. lz5I-labelled angiotensin I1 was added to plasma samples either immediately before column chromatography or to the 'inhibitor solution' into which the blood was collected. For both procedures recovery was expressed as (radioactivity in eluates before evaporationhadioactivity put on resin) x 100 (%). When the 1251-labelled angiotensin I1 was added to the plasma samples, 60% (SD 7; n = 4) was found in the eluates of the Dowex 1 (X8) columns. When I2'I-labelled angiotensin I1 was added to the freshly collected blood, the respective recovery was 55% (SD 7: n = 4). The dfierence between these values was not significant. When the 12sI-labelled angiotensin I1 was added to the plasma, 4% (SD 2; n = 8) of the radioactivity was found in the eluates of the Bio Rex 70 columns, whereas 6% (SD 4; n = 4) was found after its addition to the freshly collected blood. Thin-layer chromatography of the eluates of the Dowex 1 (X8) columns showed one peak of radioactivity (RF 0.3) corresponding to '251-labelled angiotensin 11. Thus the angiotensins found in plasma are not produced during blood collection or in the subsequent processing of the samples.
Studies on the presence of [des-Asp',desArgllangiotensin II in plasma
Since Dowex 1 (X8), which was used to extract angiotensin 11, did not allow the separation of the octapeptide from the hexapeptide metabolite [des- Asp1,des-Arg2]angiotensin 11, it was investigated whether the metabolite was after all present in rat plasma. The plasma concentrations of angiotensins were elevated by isoprenaline (500 pg/kg, intramuscularly). Eighteen minutes after the injection of isoprenaline, 1251-labelled angiotensin I1 was infused into a rat's tail vein. While the infusion was still running, the rat was lightly anaesthetized with ether and blood was collected from the aorta. Plasma samples were extracted with Dowex 1 (X8)
or Bio Rex 70. The eluates were chromatographed on thin-layer plates. In the eluates of the Dowex 1 (X8) columns, two peaks of radioactivity were found. The first peak corresponded to that of lZ5I-labelled angiotensin I1 (R,, 0. 3), and the second peak corresponded to that of unlabelled [desAsp1,des-Arg21angiotensin I1 (RF 0.4), which was run on a parallel track. The radioactivity ratio of peak l/peak 2 was 5 : 1. When experiments were performed with intravenous infusions of '251-labelled angiotensin I, Dowex 1 (X8) eluates showed two peaks of radioactivity (R, 0.3 and 0.4; ratio 5: 1) and eluates of Bio Rex 70 columns displayed one peak (RF 0.3).
(RF 0.3).
Effect of isoprenaline on the plasma concentrations of angiotensins
The time course of the effect of an intramuscular injection of isoprenaline (240 pg/lcg) on the plasma concentrations of angiotensin I11 and angiotensin 11-like material is shown in Fig. 3 . The plasma angiotensin I11 of control rats (0 min) was 20 fmol/ml (SD 15; n = 8). The concentration of angiotensin 11-like material was 60 fmol/ml (SD 35; n = 8) in controls (0 min). After the injection of isoprenaline, the plasma concentrations of the peptides increased rapidly. The maximum was obser-.ved 24 min after the injection of the amine. At 96 min after the injection the peptide concentrations had returned to control values.
The dose-response relationship of the effect of isoprenaline (60-480 pgBlkg) on the plasma concentrations of angiotensins is shown in Fig. 4 .
The maximum effect of isoprenaline was obtained with 240 pg/kg. With all doses of isoprenaline used the ratio of angiotensin 11-like material/angiotensin I11 was approximately 3 : 1.
Discussion
Like most of the antibodies used for the radioimmunological determination of angiotensin 11, our antibody does not distinguish between angiotensin I1 and its metabolites, which are produced by aminopeptidases. This disadvantage can be overcome by separation of the peptides before the radioimmunoassay. Thus the determination of angiotensin I1 or angiotensin I11 is usually performed in several steps. The first step is the extraction and concentration of the peptides, which is often done with the cationic exchange resin Dowex 50W (X2) (Duesterdieck & McElwee, 1971) . The next step is to separate the peptides. This has been performed by thin-layer chromatography (Favre et al., 1974; Mendelsohn, 1976) or paper chromatography (Semple & Morton, 1976) . 'Peptide mapping' has also been used (Bailie & Oparil, 1977) . In contrast, the method described here extracts, concentrates and separates angiotensin I11 and angiotensin 11-like material in one step. It is, in addition, simple, rapid and highly reproducible. As usual, the determination of the peptides is performed by radioimmunoassay .
Dowex 1 (X8) was used to extract angiotensin 11. While angiotensin I11 passed through this resin in the emuent, angiotensin I1 and its hexapeptide metabolite were extracted with a recovery of 54% and 5 1% respectively. These recoveries were obtained with unlabelled peptides. A separation of both peptides by Dowex 1 (X8) was not possible, which is a disadvantage, since small amounts of the hexapeptide have been reported in rat plasma (Semple & Morton, 1976) .
To investigate further whether hexapeptide is present in plasma, 1Z51-labelled angiotensin I and I1 were infused into conscious rats. After column extraction and thin-layer chromatography two peaks of radioactivity were found in the plasma of these rats. Their R, values corresponded to those of 1251-labelled angiotensiri I1 and unlabelled hexapeptide, which were run on neighbouring tracks. We therefore conclude tentatively that there was in-. deed hexapeptide in the plasma samples, although another unidentified metabolite may also have been responsible for this peak. A 5 : 1 ratio of angiotensin II/hexapeptide was found. Thus the angiotensin found in the eluates of the Dowex 1 (X8) resin should be called 'angiotensin 11-like activity'. However, this resin still offers some advantage to the widely used Dowex SOW (X2), which does not separate angiotensin 111.
Angiotensin I11 was extracted with the cationic exchange resin Bio Rex 70. Under the conditions used, the resin selectively extracted un-labelled angiotensin I11 with a recovery of 62%.
The efficiency of both extraction procedures was also tested by determining the recoveries of labelled angiotensin I1 and 111. In this case, the radioactivity added to the resin was compared with that found in the column eluate before evaporation. The recoveries, thus obtained, were usually somewhat higher than the recoveries of unlabelled peptides. This may be due to the loss of peptides during evaporation and the following steps. The detection limits for angiotensin I11 and andotensin I1 were lower than 17.5 fmol/ml and 24 fmol/ml respectively. This allowed the determination of the concentrations of angiotensin IIlike activity and angiotensin I11 in plasma of normal rats. The concentration of angiotensin I11 was 20 fmol/ml (SD 15; n = 8) in plasma of untreated rats. The basal angiotensin 11-like activity was 60 fmol/ml (SD 35; n =8). A similar value for angiotensin I1 has been reported by Semple & Morton (1976) .
The Padrenoreceptor agonist isoprenaline, which has been shown previously to increase the plasma renin concentration in rats (Peskar, Meyer, Tauchmann & Hertting, 1970), caused a time-and dose-dependent elevation of the plasma concentrations of angiotensin XI1 and angiotensin II/hexapeptide. Approximately 25% of the total concentration of angiotensins consisted of angiotensin 111. This angiotensin I11 was not produced during blood collection or the subsequent processing of the samples, since the 'inhibitor solution' effectively blocked the breakdown of angiotensin 11.
All blood samples used were drawn from the abdominal aorta. Thus the concentrations of angiotensins found in these samples are probably similar to those which were delivered to the adrenal glands. In view of this, these results may contribute to the discussion on the physiological importance of angiotensin I11 for the release of aldosterone. According to our data, approximately 25% of the biologically active angiotensins is angiotensin 111. Since angiotensin I11 has been reported to be at least as effective as, or slightly more potent than, angiotensin I1 (Peach & Chiu, 1974; Campbell et al., 1974), this peptide may have a physiological role in salt and water homeostasis.
However, in view of the higher concentration of angiotensin I1 in arterial plasma, the octapeptide is probably of greater importance, unless there is a significant production of angiotensin 111 within the adrenal gland, as has been postulated by Goodfriend & Peach (1975) .
